Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
Start Date
1/1/2023
Completion Date
12/1/2024
Summary
The purpose of this study is to validate the ability of the STRATICYTE™ predictive model to predict the transformation of oral potentially malignant disorders (OPMDs) to oral squamous cell carcinoma (OSCC) in a retrospective cohort of patients who received biopsies.
Detailed Description
The study objectives are to: 1. Evaluate STRATICYTE™ sensitivity and specificity in a cohort of patients that meet the inclusion/exclusion criteria. 2. Identify patient and clinical characteristics influencing the sensitivity and specificity of the STRATICYTE™ model. 3. Estimate the correlation between STRATICYTE™ outcome and time to a positive diagnosis of oral cancer.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
STRATICYTE™ Test
Conditions
Locations
The University of Alabama at Birmingham
Birmingham, Alabama 35233
United States
Loma Linda University
Loma Linda, California 92350
United States
Minnesota Oral and Facial Surgery
Minneapolis, Minnesota 55415
United States
MD Anderson Cancer Cetner
Houston, Texas 44907
United States
UTHealth Houston School of Dentistry
Houston, Texas 77054
United States